PYRUVATE AND LACTATE METABOLISM IN THE IN-VIVO DOG HEART

Pyruvate increases the phosphorylation potential in perfused heart to a greater extent than the closely correlated substrate L-lactate. Therefore, metabolism of these compounds was studied in the myocardium of intact dogs. Phosphocreatine/ATP was increased 23% at 5.3 mM plasma pyruvate but was not significantly increased by lactate except at the highest concentration (17.5 mM in blood). Calculated [ADP] fell during pyruvate infusion from 51.5 +/- 2.0 to 38.6 +/- 3.3 muM but did not change significantly during lactate infusion. Intracellular free [Mg2+] fell from 705 +/- 53 to 498 +/- 30 muM at the highest pyruvate infusion and from 692 +/- 112 to 417 +/- 19 muM with lactate infusion. Extraction of both substrates was linear at low concentrations, reaching 0.56 mumol lactate.min-1.g wet wt-1 at 17.5 mM blood lactate and 0.58 mumol pyruvate.min-1.g wet wt-1 at 5.3 mM plasma pyruvate. Therefore, lactate uptake was almost five times lower than pyruvate uptake at similar concentrations. Elevated pyruvate (>3 mM) resulted in almost complete inhibition of net lactate uptake. Infused [3-C-13]lactate or -pyruvate gave rise to labeled glutamate and alanine in vivo, but labeled lactate was not visible when [3-C-13]pyruvate was the substrate. The C-13 enrichment of myocardial lactate was similar to alanine and acetyl CoA with infused [3-C-13]lactate but was only one-half that of alanine and acetyl CoA when [3-C-13]-pyruvate was the substrate, indicating a possible inhibition of lactate dehydrogenase.